Latest news for Aion Therapeutic (OTC:ANTCF) Stock

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

News

Penny Stocks

ANTCF


	Canadian convenience store operator Alimentation Couche-Tard (OTC: ANTCF) has signed agreements covering TotalEnergies SE&#39;s (NYSE: TTE) retail networks in four European countries.


Couche-Tard Lands Deal To Buy Certain European Assets Of TotalEnergies For €3.1B

AION THERAPEUTIC INC by AION Therapeutic Inc.

Aion Therapeutic Inc

WIIM

LSCC

Lattice Semiconductor shares are trading lower after the company reported worse-than-expected Q2 financial results and issued weak Q3 revenue guidance.

Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.33 by 15.15 percent. This is a 5.56 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $9.380 million which beat the analyst consensus estimate of $8.742 million by 7.30 percent. This is a 3.19 percent increase over sales of $9.090 million the same period last year.

Earnings

Earnings Beats

SEVN

Seven Hills Realty Trust Q2 2024 Adj. EPS $0.38 Beats $0.33 Estimate, Sales $9.380M Beat $8.742M Estimate

SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent.

SES AI Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate

Cryptocurrency markets are trading sideways, as Elon Musk weighs in on <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40018603/elon-musk-has-a-soft-spot-for-dogecoin-warns-followers-if-you-see-me-pumping-crypto-its-no">growing crypto adoption</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$67,266</td>
<td>-1.3%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)&nbsp;</td>
<td>$3,309&nbsp;</td>
<td>+1%</td>
</tr>
<tr>
<td>Solana&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$186.7</td>
<td>+0.9%</td>
</tr>
<tr>
<td>Dogecoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1294</td>
<td>-0.5%</td>
</tr>
<tr>
<td>Shiba Inu&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001676</td>
<td>-0.4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume declining by 36.2% and a 16% fall in daily active addresses. However, exchange netflows increased by 14.6%. Currently, 93% of Bitcoin holders are making a profit, while 5% are at breakeven.</li>
<li>Coinglass data shows 43,849 traders liquidated in the past 24 hours, with total liquidations at $181.7 million. Bitcoin's open interest spiked to $37.5 billion, the highest level since June 7.</li>
<li>Watcher Guru data <a href="https://x.com/WatcherGuru/status/1817975382882324529">highlighted</a> the U.S. government moving $2 billion worth of BTC to a new address. This comes on the heels of Donald Trump saying he would create a strategic national Bitcoin stockpile and the government would keep 100% of the Bitcoin it owns if he was elected.</li>
<li>The U.S. Marshall Service is <a href="https://x.com/martypartymusic/status/1817986519019241981">sending</a> Bitcoin to Coinbase for custodianship but not to sell. The contract is valued at $32.5 million and structured as a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) agreement, with an initial ordering period of five years.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40017408/will-bitcoin-surge-past-70-000-10x-research-highlights-key-factors-to-watch">Will Bitcoin Surge Past $70,000? 10x Research Highlights Key Factors To Watch</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40009393/crypto-related-stocks-like-coinbase-marathon-digital-and-others-surge-after-trumps-pro-bit">Crypto Related Stocks Like Coinbase, Marathon Digital And Others Surge After Trump&#8217;s Pro-Bitcoin Comments</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40014390/university-of-wyoming-launches-first-ever-academic-bitcoin-research-institute">University Of Wyoming Launches First-Ever Academic Bitcoin Research Institute</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40007277/if-michael-saylors-13m-forecast-for-bitcoin-in-2045-comes-true-btc-market-cap-will-be-bigg">If Michael Saylor&#8217;s $13M Forecast For Bitcoin In 2045 Comes True, BTC Market Cap Will Be Bigger Than Combined GDP Of Top 10 Countries, But How Likely Is It?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40003944/pro-bitcoin-demographic-will-boost-trumps-vote-share-by-at-least-1-predicts-vivek-ramaswam">Pro-Bitcoin Demographic Will Boost Trump&#8217;s Vote Share By At Least 1%, Predicts Vivek Ramaswamy</a></li>
</ul>
<h3 class="wp-block-heading">Top Gainers: </h3>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/–</td>
</tr>
<tr>
<td>Book Of Meme (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BOME</a>)</td>
<td>$0.01014</td>
<td>+13%</td>
</tr>
<tr>
<td>Bitcoin SV (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BSV</a>)</td>
<td>52.04</td>
<td>+12%</td>
</tr>
<tr>
<td>MOG Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MOG</a>)</td>
<td>$0.000001892&nbsp;</td>
<td>+7.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader CrypNuevo is curious if the choppy price action persists until the FOMC meeting on Wednesday. He adds that whenever there is a big event like this, "markets tend to be choppy until the news come out. Big players step in with caution. Not an easy week."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> update: Choppy price action within the orange box until FOMC on Wednesday? Yes, that&#39;s what it seems to be happening so far. When there is a big event like this FOMC, markets tend to be choppy until the news come out. Big players step in with caution. Not an easy week &#x1f44d; <a href="https://t.co/dkNpIouvw4">https://t.co/dkNpIouvw4</a> <a href="https://t.co/ahsqAANV9T">pic.twitter.com/ahsqAANV9T</a>
&mdash; CrypNuevo &#x1f528; (@CrypNuevo) <a href="https://twitter.com/CrypNuevo/status/1817963216950919381?ref_src=twsrc%5Etfw">July 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Cryptoquant founder &amp; CEO Ki Young Ju sees Bitcoin entering the U.S.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> is entering the United States. <a href="https://t.co/QW9B2cm3Ep">pic.twitter.com/QW9B2cm3Ep</a>
&mdash; Ki Young Ju (@ki_young_ju) <a href="https://twitter.com/ki_young_ju/status/1817990999152472364?ref_src=twsrc%5Etfw">July 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Altcoin Sherpa <a href="https://x.com/AltcoinSherpa/status/1817985686362054656">predicts</a> Bitcoin's path to $100,000 is programmed, but with some bumps on the way. He suggests, "Don&#8217;t get shaken out and lose yourself along the way."
In a cautionary <a href="https://x.com/EmperorBTC/status/1817967853045428336">tweet</a>, crypto trader Emperor advises that buying when prices are at a big resistance, expecting a breakout is interesting but stupid. He indicates that instead, it is at that level when the market turns excited. "So many people entered at $70,000 when the entry was at $63,500."
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40016374/bitcoin-super-cycle-will-cause-daily-pumps-of-10-30-trader-predicts-until-then-every-dip-i">Bitcoin &#8216;Super Cycle&#8217; Will Cause Daily Pumps Of 10-30%, Trader Predicts: &#8216;Until Then, Every Dip Is A Massive Buying Opportunity&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BOME

$BSV

$BTC

$DOGE

$ETH

$MOG

$SHIB

$SOL

Bitcoin, Dogecoin Erase Earlier Gains, Ethereum Holding On: 'Choppy Price Action Until FOMC On Wednesday,' Predicts Trader

Updated previously provided same property NOI growth expectations for 2024 to&nbsp;4.25%&nbsp;-&nbsp;5.00%&nbsp;from&nbsp;3.50%&nbsp;-&nbsp;4.25%.

Guidance

Brixmor Property Updates Nareit FFO Per Share Expectations For 2024 From $2.08 - $2.11 To $2.11 - $2.14 (Est $2.10)

HSII

Heidrick & Struggles Sees Q3 Consolidated Net Revenue $260M-$280M vs $258.77M Est.

AMRX

Amneal Pharmaceuticals Receives FDA Approval For New Potassium Phosphates IV Infusion Bag; First Preservative-Free Single-Dose Presentation; Third 505(b)(2) Injectable Added This Year, Launching In Q3

Pathfinder Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBHC#NASDAQ">PBHC</a>) reported quarterly earnings of $0.32 per share. This is unchanged from the same period last year.

PBHC

Pathfinder Bancorp Q2 EPS $0.32, Same YoY

Results to be announced at 8:00 a.m. Eastern time, conference call to begin at 8:30 a.m. Eastern time
LAWRENCEVILLE, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, will issue a news release announcing topline results from the Phase 2 OVATION 2 Study with IMNN-001 in patients with advanced ovarian cancer tomorrow, July 30, at approximately 8:00 a.m. Eastern time, and will host an investment community conference call to discuss the results and answer questions at 8:30 a.m. Eastern time. IMNN-001 is the Company's interleukin-12 (IL-12) immunotherapy based on its TheraPlas&#x2122; technology.
To participate in the conference call, please dial 833-816-1132 (Toll-Free/North America) or 412-317-0711 (International/Toll) and ask for the IMUNON call. A live webcast of the call will be available <a href="https://www.globenewswire.com/Tracker?data=Bm3hfh9dyK0Neb6mzBWgxp1JBeVE_CgLqZ3VZxs0heVMW70IMybyS4q9Nk_qdaictNDINAjqkBU4dKyRTP5_NeRyi_lmn7b3KA4NKx-U3sPbvCBamMhLCxJws1qLfo8dyMZ6GUAb5iEazWw_l8luqw==">here</a>.
Participants are encouraged to preregister for the call <a href="https://www.globenewswire.com/Tracker?data=Bm3hfh9dyK0Neb6mzBWgxnK6Uxu24MhI8i7wx6myYP1hMJz6iJf-K7u9l6RlP6Gi9D5FhhgVJx6se6qx1LWLW4G-yLghqucIHTb50gTdfzo=">here</a>.
The call will be archived for replay through August 13, 2024. The replay can be accessed at 877-344-7529 (U.S. Toll-Free), 855-669-9658 (Canada Toll-Free) or 412-317-0088 (International Toll), using the replay access code 7783601. A webcast of the call will be available <a href="https://www.globenewswire.com/Tracker?data=Bm3hfh9dyK0Neb6mzBWgxiY9FdsJddUYKKXJDD95OCxe1-IfINAUn9nCZbr6xfN6bgrkyPkKXjG5h0XCL5hCovh9NNkhsokQEumV3t0v3XbdABRLUJlYVwt1vdqC5HpU">here</a> for 90 days.

Biotech

General

IMNM

IMUNON To Report Topline Results From The Phase 2 OVATION 2 Study With IMNN-001 In Advanced Ovarian Cancer July 30, At ~8:00 a.m. ET

CLSD

Clearside Biomedical Partner Arctic Vision Reports Phase 3 Results For ARCATUS In Uveitic Macular Edema; NDAs For ARCATUS Accepted In Australia And Singapore

VRNS

Varonis Raises FY24 Revenue Guidance From $536M - $546M To $544M - $552M (Est $542.242M), Adj EPS From $0.13 - $0.16 To $0.22 - $0.24 (Est $0.17)

CNO Financial Group Raising Full-Year Guidance On Earnings And Cash Flow

Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares are falling after the company reported its second-quarter financial results Monday. Here's a look at the key<a href="https://www.benzinga.com/pressreleases/24/07/b40021715/lattice-semiconductor-reports-second-quarter-2024-results"> figures from the report. </a>
The Details: Lattice Semiconductor reported quarterly earnings of 23 cents per share, which missed the analyst consensus estimate of 24 cents and is a 55.77% decrease from the same period last year.
Quarterly sales came in at $124.076 million, which missed the analyst consensus estimate of $130.172 million by 4.68% and represents a 34.72% decrease from the same period last year. Gross margin was 69%.
Read Also: <a href="https://www.benzinga.com/news/24/07/39989347/whats-going-on-with-lululemon-stock">What&#8217;s Going On With Lululemon Stock?</a>
&#8220;Second quarter 2024 results reflect the impact of cyclic industry headwinds. While the industry continues to go through a period of inventory normalization, we are starting to see signs of improvement. We continue to execute on our ongoing product portfolio expansion and remain well positioned for long-term growth,&#8221; said Esam Elashmawi, interim CEO of Lattice.
Outlook:  Lattice expects revenue for the third quarter of 2024 to be between $117 million and $137 million and gross margin to be 69%, plus or minus 1%.
LSCC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Lattice Semiconductor shares are down 10.39% after-hours at $49.25 at the time of publication Monday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984639/carbon-revolution-stock-races-on-chevrolet-corvette-zr1-wheels">Carbon Revolution Stock Races On Chevrolet Corvette ZR1 Wheels</a></li>
</ul>
Photo: Courtesy of Lattice Semiconductor Corporation

After-Hours Center

Movers

Tech

Lattice Semiconductor Stock Falls On Worse-Than-Expected Q2 Results

Lattice Semiconductor Sees Q3 Revenue $117M-$137M vs $142.47M Est.

CENT

CORRECTION: Central Garden & Pet Company To Report On August 7, 2024

T2 Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.97) by 31.96 percent. The company reported quarterly sales of $1.952 million which missed the analyst consensus estimate of $2.100 million by 7.05 percent. This is a 0.61 percent decrease over sales of $1.964 million the same period last year.

Earnings Misses

TTOO

T2 Biosystems Q2 2024 GAAP EPS $(0.66) Beats $(0.97) Estimate, Sales $1.952M Miss $2.100M Estimate

COPT Defense Properties Sees FY 2024 Diluted EPS $2.51-$2.57 Vs $1.19 - $1.25 Prior

CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.71 by 47.89 percent. This is a 94.44 percent increase over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $1.07 billion which beat the analyst consensus estimate of $943.98 million by 12.93 percent. This is a 4.31 percent increase over sales of $1.02 billion the same period last year.

CNO Finl Group Q2 Adj $1.05 Beats $0.71 Estimate, Sales $1.07B Beat $943.98M Estimate

PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. This is a 183.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $320.671 million which beat the analyst consensus estimate of $304.760 million by 5.22 percent. This is a 30.30 percent increase over sales of $246.101 million the same period last year.

PotlatchDeltic Q2 2024 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $320.671M Beat $304.760M Estimate

Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. The company reported quarterly sales of $4.950 million which missed the analyst consensus estimate of $5.171 million by 4.27 percent. This is a 5.25 percent increase over sales of $4.703 million the same period last year.

EKSO

Ekso Bionics Holdings Q2 2024 GAAP EPS $(0.13) Beats $(0.14) Estimate, Sales $4.950M Miss $5.171M Estimate

Aion Therapeutic

<ul>
	<li>Canadian convenience store operator&nbsp;Alimentation Couche-Tard&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ANTCF#OTC">ANTCF</a>) has signed agreements covering&nbsp;TotalEnergies SE&#39;s&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) retail networks in four European countries.</li>
	<li>The proposed acquisition would comprise 100% of TotalEnergies retail assets in Germany and the Netherlands and a 60% controlling interest in the Belgium and Luxembourg entities.</li>
	<li>The planned transaction, based on an enterprise value of &euro;3.1 billion, covers the service station networks and the B2B fuel card activities.</li>
	<li>The deal includes 2,193 sites located in Germany, Belgium, Netherlands and Luxemburg.</li>
	<li>In Belgium and Luxembourg, TotalEnergies and Couche-Tard will form a 40-60 joint venture, owning and operating 619 service stations.</li>
	<li>In Germany and the Netherlands, TotalEnergies will sell 100% of its networks to Couche-Tard, including 1,198 service stations in Germany and 392 in the Netherlands.</li>
	<li>TotalEnergies will retain its activities related to off-station electric vehicle charging, hydrogen retail and wholesale fuel business, and the AS 24 service station network for trucks.</li>
	<li>For calendar 2022, EBITDA was &euro;500 million for the entities covered by this proposed transaction.</li>
	<li>This deal supports TotalEnergies&#39; goal of being a multi-energy corporation and its vision to help society achieve net zero by 2050.</li>
	<li>The transaction is expected to close by the end of 2023.</li>
	<li>Alimentation Couche-Tard has&nbsp;<a class="editor-rtfLink" href="https://corpo.couche-tard.com/en/newsroom/press-releases/" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">access to $3.7 billion</a>&nbsp;through its available cash and operating credit facility as of January 29, 2023.</li>
	<li>Price Action:&nbsp;TTE shares are trading lower by 1.15% at $56.69 in premarket on Thursday.</li>
</ul>

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Aion Therapeutic

News

Latest news for Aion Therapeutic (OTC:ANTCF) Stock

Thursday, March 16, 2023